Dysphagia in schizophrenia: pathological mechanisms and treatment recommendations
Frontiers in Psychiatry · 17.09.2024 · 15
DOI: 10.3389/fpsyt.2024.1448623 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Psychiatry, online erschienen am 17.09.2024. Verfasst von Jiahui Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Daizhuang Hospital, Jining, Shandong, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Dysphagie
Abstract (Originalsprache)
Schizophrenia is a chronic, severe, and disabling mental disorder that significantly impacts individuals’ lives. Long-term treatment with antipsychotic drugs, coupled with the complications of the disease itself, increases the risk of dysphagia in patients. These disorders further heighten the likelihood of choking and asphyxia death among this population. This project aims to comprehensively review the pathological mechanisms behind dysphagia in schizophrenia, alongside proposing early screening and evaluation methods. It also suggests treatment recommendations to mitigate the risks and complications associated with dysphagia in these patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shandong Daizhuang Hospital, Jining, Shandong, China.
Zitieren
APA
Wang, J., Gao, C., Fu, C., & Li, K. (2024). Dysphagia in schizophrenia: pathological mechanisms and treatment recommendations. Frontiers in Psychiatry, 15. https://doi.org/10.3389/fpsyt.2024.1448623
Vancouver
Wang J, Gao C, Fu C, Li K. Dysphagia in schizophrenia: pathological mechanisms and treatment recommendations. Frontiers in Psychiatry. 2024;15. doi:10.3389/fpsyt.2024.1448623
BibTeX
@article{Wang2024,
author = {Wang, Jiahui and Gao, Caifeng and Fu, Cuiyuan and Li, Kun},
title = {Dysphagia in schizophrenia: pathological mechanisms and treatment recommendations},
journal = {Frontiers in Psychiatry},
year = {2024},
volume = {15},
doi = {10.3389/fpsyt.2024.1448623}
}
EUVIMED